InnovaDerma PLC's (LON:IDP) chairman Joe Bayer and CEO Kieran Callan tell Proactive London's Andrew Scott the business has performed resiliently during the coronavirus pandemic lockdown but have been hit by rising advertising costs. Bayer says they now want to start swinging the earnings pendulum towards bridging the gap between first and second half seasonality impacts and adds they're looking for more growth. ''We're focused and have come through the worst of it and are looking for a better future''.
InnovaDerma reports strong cash and 'resilient performance' during pandemic
Quick facts: InnovaDerma PLC
Price: 59.9 GBX
Market Cap: £8.68 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of InnovaDerma PLC named herein, including the promotion by the Company of InnovaDerma PLC in any Content on the Site, the Company receives from...FOR OUR FULL DISCLAIMER CLICK HERE